The Rights Issue Committee of the Company at its meeting held today, i.e. on July 15, 2025 has considered and approved the terms of Rights Issue of Equity Shares.

pdf

Valiant Laboratories Ltd.

15 Jul 2025

102.79

-5.00%

Corp. Note

Valiant Laboratories Ltd - 543998 - Board Meeting Outcome for Approval Of Terms Of Rights Issue …

BSE India

The Rights Issue Committee of the Company at its meeting held today i.e. on July 15, 2025, has, inter alia, considered and approved the Rights Issue Price, Issue Size, Terms of Payment, Record Date, Rights Issue Period, Rights Entitlement Ratio and other terms of Rights Issue

pdf

Valiant Laboratories Ltd.

11 Jul 2025

102.79

-5.00%

Company Update

Valiant Laboratories Ltd - 543998 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under 74(5) for the Quarter ended June 30, 2025

pdf

Valiant Laboratories Ltd.

10 Jul 2025

102.79

-5.00%

Company Update

Valiant Laboratories Ltd - 543998 - Draft Letter Of Offer For Proposed Rights Issue Of Equity …

BSE India

Draft letter of offer for proposed rights issue of equity shares

pdf

Valiant Laboratories Ltd.

09 Jul 2025

102.79

-5.00%

Company Update

Valiant Laboratories Ltd - 543998 - Contact Details Of Key Managerial Personnel Of The Company Authorized …

BSE India

Contact details of Key Managerial Personnel of the Company authorised under Regulation 30(5) of SEBI (LODR) Regulations, 2015

pdf

Valiant Laboratories Ltd.

09 Jul 2025

102.79

-5.00%

Company Update

Valiant Laboratories Ltd - 543998 - Appointment of Company Secretary and Compliance Officer

BSE India

Appointed Mr. Akshay Gangurde (ICSI Membership Number: A70561) as the Company Secretary and Compliance Officer of the Company with effect from July 09, 2025.

pdf

47.18% Gain from 52W Low

High vol. this week

Valiant Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Valiant Laboratories Ltd. on BSE